Prion Protein and its conformational conversion: A structural perspective

Topics in Current Chemistry

Volumn 305, Issue , 2011, Pages 135-168

  Surewicz, Witold K ^a   Apostol, Marcin I ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Prion diseases; Prion protein folding; Prion strains; Prion structural biology; Prions

Indexed keywords

COPPER; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BIOPHYSICS; CHEMISTRY; GENETIC POLYMORPHISM; HUMAN; METABOLISM; METHODOLOGY; PATHOLOGY; PRION; PRION DISEASE; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE;

ANIMALS; BIOPHYSICS; COPPER; HUMANS; POLYMORPHISM, GENETIC; PRION DISEASES; PRIONS; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS;

EID: 80054774250     PISSN: 03401022     EISSN: None     Source Type: Book Series    
DOI: 10.1007/128_2011_165     Document Type: Article

References (186)

1. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95:13363-13383 (Pubitemid 28525623)
2. Chien P, Weissman JS, DePace AH (2004) Emerging principles of conformation-based prion inheritance. Annu Rev Biochem 73:617-656 (Pubitemid 39050382)
3. Wopfner F, Weidenhofer G, Schneider R et al (1999) Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J Mol Biol 289: 1163-1178 (Pubitemid 29296697)
4. Hornemann S, Schorn C, Wuthrich K (2004) NMR structure of the bovine prion protein isolated from healthy calf brains. EMBO Rep 5:1159-1164 (Pubitemid 40103610)
5. Riek R, Hornemann S, Wider G et al (1997) NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett 413:282-288 (Pubitemid 27353285)
6. Donne DG, Viles JH, Groth D et al (1997) Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc Natl Acad Sci USA 94: 13452-13457
7. Burns CS, Aronoff-Spencer E, Dunham CM et al (2002) Molecular features of the copper binding sites in the octarepeat domain of the prion protein. Biochemistry 41:3991-4001 (Pubitemid 34251038)
8. Zahn R (2003) The octapeptide repeats in mammalian prion protein constitute a pH-dependent folding and aggregation site. J Mol Biol 334:477-488 (Pubitemid 37386348)
9. Taubner LM, Bienkiewicz EA, Copié V et al (2010) Structure of the flexible amino-terminal domain of prion protein bound to a sulfated glycan. J Mol Biol 395:475-490
10. Aronoff-Spencer E, Burns CS, Avdievich NI et al (2000) Identification of the Cu2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. Biochemistry 39:13760-13771
11. Burns CS, Aronoff-Spencer E, Legname G et al (2003) Copper coordination in the fulllength, recombinant prion protein. Biochemistry 42:6794-6803 (Pubitemid 36666120)
12. Caughey B, Baron GS (2006) Prions and their partners in crime. Nature 443:803-810 (Pubitemid 44622685)
13. Linden R, Martins VR, PradoMAMet al (2008) Physiology of the prion protein. Physiol Rev 88:673-728 (Pubitemid 351520090)
14. Prusiner SB, Groth DF, Bolton DC et al (1984) Purification and structural studies of a major scrapie prion protein. Cell 38:127-134 (Pubitemid 15216542)
15. Hundt C, Gauczynski S, Leucht C et al (2003) Intra-and interspecies interactions between prion proteins and effects of mutations and polymorphisms. Biol Chem 384:791-803 (Pubitemid 36747940)
16. Rigter A, Langeveld JPM, Timmers-Parohi D et al (2007) Mapping of possible prion protein self-interaction domains using peptide arrays. BMC Biochem 8:6
17. Goldfarb LG, Brown P, McCombie WR et al (1991) Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci USA 88:10926-10930 (Pubitemid 21915952)
18. Chiesa R, Piccardo P, Ghetti B et al (1998) Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21:1339-1351 (Pubitemid 29022536)
19. Chiesa R, Drisaldi B, Quaglio E et al (2000) Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation. Proc Natl Acad Sci USA 97:5574-5579 (Pubitemid 30313760)
20. Chiesa R, Pestronk A, Schmidt RE et al (2001) Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation. Neurobiol Dis 8:279-288 (Pubitemid 32382481)
21. Zhang Y, Swietnicki W, Zagorski MG et al (2000) Solution structure of the E200K variant of human prion protein. Implications for the mechanism of pathogenesis in familial prion diseases. J Biol Chem 275:33650-33654
22. Ilc G, Giachin G, Jaremko Met al (2010) NMR structure of the human prion protein with the pathological Q212P mutation reveals unique structural features. PLoS ONE 5:e11715
23. Lee S, Antony L, Hartmann R et al (2010) Conformational diversity in prion protein variants influences intermolecular beta-sheet formation. EMBO J 29:251-262
24. Knaus KJ, Morillas M, Swietnicki W et al (2001) Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat Struct Biol 8:770-774 (Pubitemid 32803594)
25. Antonyuk SV, Trevitt CR, Strange RW et al (2009) Crystal structure of human prion protein bound to a therapeutic antibody. Proc Natl Acad Sci USA 106:2554-2558
26. Zahn R, Liu A, Luhrs T et al (2000) NMR solution structure of the human prion protein. Proc Natl Acad Sci USA 97:145-150 (Pubitemid 30055798)
27. Calzolai L, Zahn R (2003) Influence of pH on NMR structure and stability of the human prion protein globular domain. J Biol Chem 278:35592-35596 (Pubitemid 37102332)
28. Wuthrich K, Riek R (2001) Three-dimensional structures of prion proteins. Adv Protein Chem 57:55-82 (Pubitemid 32622680)
29. Hornemann S, Christen B, von Schroetter C et al (2009) Prion protein library of recombinant constructs for structural biology. FEBS J 276:2359-2367
30. Riek R, Hornemann S, Wider G et al (1996) NMR structure of the mouse prion protein domain PrP(121-321). Nature 382:180-182 (Pubitemid 26242887)
31. López Garcia F, Zahn R, Riek R et al (2000) NMR structure of the bovine prion protein. Proc Natl Acad Sci USA 97:8334-8339 (Pubitemid 30639673)
32. Lysek DA, Schorn C, Nivon LG et al (2005) Prion protein NMR structures of cats, dogs, pigs, and sheep. Proc Natl Acad Sci USA 102:640-645 (Pubitemid 40282718)
33. Calzolai L, Lysek DA, Pérez DR et al (2005) Prion protein NMR structures of chickens, turtles, and frogs. Proc Natl Acad Sci USA 102:651-655 (Pubitemid 40282720)
34. Haire LF, Whyte SM, Vasisht N et al (2004) The crystal structure of the globular domain of sheep prion protein. J Mol Biol 336:1175-1183 (Pubitemid 38229705)
35. Gossert AD, Bonjour S, Lysek DA et al (2005) Prion protein NMR structures of elk and of mouse/elk hybrids. Proc Natl Acad Sci USA 102:646-650 (Pubitemid 40282719)
36. Sigurdson CJ, Nilsson KPR, Hornemann S et al (2009) De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc Natl Acad Sci USA 106:304-309
37. Sigurdson CJ, Nilsson KPR, Hornemann S et al (2010) A molecular switch controls interspecies prion disease transmission in mice. J Clin Invest 120:2590-2599
38. Mead S (2006) Prion disease genetics. Eur J Hum Genet 14:273-281
39. van der Kamp MW, Daggett V (2009) The consequences of pathogenic mutations to the human prion protein. Protein Eng Des Sel 22:461-468
40. Hosszu LLP, TattumMH, Jones S et al (2010) The H187Rmutation of the human prion protein induces conversion of recombinant prion protein to the PrP(Sc)-like form. Biochemistry 49:8729-8738
41. Eghiaian F, Grosclaude J, Lesceu S et al (2004) Insight into the PrPC-PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants. Proc Natl Acad Sci USA 101:10254-10259 (Pubitemid 38924912)
42. Alperovitch A, Zerr I, Pocchiari M et al (1999) Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 353:1673-1674 (Pubitemid 29224526)
43. Mead S, Stumpf MPH, Whitfield J et al (2003) Balancing selection at the prion protein gene consistent with prehistoric Kurulike epidemics. Science 300:640-643 (Pubitemid 36520588)
44. Brandel J, Preece M, Brown P et al (2003) Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet 362:128-130 (Pubitemid 36831026)
45. Janowski R, Kozak M, Jankowska E et al (2001) Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat Struct Biol 8:316-320 (Pubitemid 32275015)
46. Liu Y, Gotte G, Libonati M et al (2002) Structures of the two 3D domain-swapped RNase A trimers. Protein Sci 11:371-380 (Pubitemid 34075800)
47. Liu Y, Eisenberg D (2002) 3D domain swapping: as domains continue to swap. Protein Sci 11:1285-1299 (Pubitemid 34547201)
48. Sambashivan S, Liu Y, Sawaya MR et al (2005) Amyloid-like fibrils of ribonuclease A with three-dimensional domain-swapped and native-like structure. Nature 437:266-269 (Pubitemid 41294490)
49. Viles JH, Klewpatinond M, Nadal RC (2008) Copper and the structural biology of the prion protein. Biochem Soc Trans 36:1288-1292
50. Davies P, Brown DR (2008) The chemistry of copper binding to PrP: is there sufficient evidence to elucidate a role for copper in protein function? Biochem J 410:237-244 (Pubitemid 351346181)
51. Jackson GS (2001) Location and properties of metal-binding sites on the human prion protein. Proc Natl Acad Sci USA 98:8531-8535 (Pubitemid 32678062)
52. Kramer ML, Kratzin HD, Schmidt B et al (2001) Prion protein binds copper within the physiological concentration range. J Biol Chem 276:16711-16719
53. Garnett AP, Viles JH (2003) Copper binding to the octarepeats of the prion protein. Affinity, specificity, folding, and cooperativity: insights from circular dichroism. J Biol Chem 278: 6795-6802 (Pubitemid 36800668)
54. Walter ED, Chattopadhyay M, Millhauser GL (2006) The affinity of copper binding to the prion protein octarepeat domain: evidence for negative cooperativity. Biochemistry 45: 13083-13092 (Pubitemid 44763431)
55. Wells MA, Jelinska C, Hosszu LLP et al (2006) Multiple forms of copper (II) co-ordination occur throughout the disordered N-terminal region of the prion protein at pH 7.4. Biochem J 400:501-510 (Pubitemid 44974462)
56. Hasnain SS, Murphy LM, Strange RW et al (2001) XAFS study of the high-affinity copperbinding site of human PrP(91-231) and its low-resolution structure in solution. J Mol Biol 311:467-473 (Pubitemid 32816582)
57. Jones CE, Abdelraheim SR, Brown DR et al (2004) Preferential Cu2+ coordination by His96 and His111 induces beta-sheet formation in the unstructured amyloidogenic region of the prion protein. J Biol Chem 279:32018-32027 (Pubitemid 39014646)
58. Klewpatinond M, Davies P, Bowen S et al (2008) Deconvoluting the Cu2+ binding modes of full-length prion protein. J Biol Chem 283:1870-1881
59. Cereghetti GM, Schweiger A, Glockshuber R et al (2001) Electron paramagnetic resonance evidence for binding of Cu(2+) to the C-terminal domain of the murine prion protein. Biophys J 81:516-525 (Pubitemid 32605989)
60. Walter ED, Stevens DJ, Spevacek AR et al (2009) Copper binding extrinsic to the octarepeat region in the prion protein. Curr Protein Pept Sci 10:529-535
61. Hijazi N, Shaked Y, Rosenmann H et al (2003) Copper binding to PrPC may inhibit prion disease propagation. Brain Res 993:192-200 (Pubitemid 37464597)
62. Sigurdsson EM, Brown DR, Alim MA et al (2003) Copper chelation delays the onset of prion disease. J Biol Chem 278:46199-46202 (Pubitemid 37452189)
63. Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75:333-366 (Pubitemid 44118036)
64. Wildegger G, Liemann S, Glockshuber R (1999) Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates. Nat Struct Biol 6:550-553 (Pubitemid 29252834)
65. Hosszu LLP, Wells MA, Jackson GS et al (2005) Definable equilibrium states in the folding of human prion protein. Biochemistry 44:16649-16657 (Pubitemid 41832045)
66. Apetri AC, Surewicz K, Surewicz WK (2004) The effect of disease-associated mutations on the folding pathway of human prion protein. J Biol Chem 279:18008-18014 (Pubitemid 38560570)
67. Apetri AC, Surewicz WK (2002) Kinetic intermediate in the folding of human prion protein. J Biol Chem 277:44589-44592 (Pubitemid 36159046)
68. Apetri AC, Maki K, Roder H et al (2006) Early intermediate in human prion protein folding as evidenced by ultrarapid mixing experiments. J Am Chem Soc 128:11673-11678 (Pubitemid 44338858)
69. Caughey B, Raymond GJ, Ernst D et al (1991) N-Terminal truncation of the scrapieassociated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol 65:6597-6603
70. Hart T, Hosszu LLP, Trevitt CR et al (2009) Folding kinetics of the human prion protein probed by temperature jump. Proc Natl Acad Sci USA 106:5651-5656
71. Swietnicki W, Petersen RB, Gambetti P et al (1998) Familial mutations and the thermodynamic stability of the recombinant human prion protein. J Biol Chem 273:31048-31052
72. Liemann S, Glockshuber R (1999) Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry 38:3258-3267
73. Swietnicki W, Petersen R, Gambetti P et al (1997) pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231). J Biol Chem 272:27517-27520 (Pubitemid 27473537)
74. Hornemann S, Glockshuber R (1998) A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH. Proc Natl Acad Sci USA 95:6010-6014 (Pubitemid 28248955)
75. Swietnicki W, Morillas M, Chen SG et al (2000) Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. Biochemistry 39:424-431 (Pubitemid 30056478)
76. Morillas M, Vanik DL, Surewicz WK (2001) On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein. Biochemistry 40:6982-6987 (Pubitemid 32538246)
77. Julien O, Chatterjee S, Thiessen A et al (2009) Differential stability of the bovine prion protein upon urea unfolding. Protein Sci 18:2172-2182
78. Jenkins DC, Sylvester ID, Pinheiro TJT (2008) The elusive intermediate on the folding pathway of the prion protein. FEBS J 275:1323-1335 (Pubitemid 351342226)
79. Kuwata K, Li H, Yamada H et al (2002) Locally disordered conformer of the hamster prion protein: a crucial intermediate to PrPSc? Biochemistry 41:12277-12283
80. Torrent J, Alvarez-Martinez MT, Heitz F et al (2003) Alternative prion structural changes revealed by high pressure. Biochemistry 42:1318-1325 (Pubitemid 36184073)
81. Martins SM, Chapeaurouge A, Ferreira ST (2003) Folding intermediates of the prion protein stabilized by hydrostatic pressure and low temperature. J Biol Chem 278:50449-50455 (Pubitemid 37548890)
82. Kachel N, Kremer W, Zahn R et al (2006) Observation of intermediate states of the human prion protein by high pressure NMR spectroscopy. BMC Struct Biol 6:16
83. Kuwata K, Kamatari YO, Akasaka K et al (2004) Slow conformational dynamics in the hamster prion protein. Biochemistry 43:4439-4446 (Pubitemid 38500572)
84. Prusiner SB (1991) Molecular biology of prion diseases. Science 252:1515-1522 (Pubitemid 21917065)
85. Kocisko DA, Come JH, Priola SA et al (1994) Cell-free formation of protease-resistant prion protein. Nature 370:471-474 (Pubitemid 24263553)
86. Maiti NR, Surewicz WK (2001) The role of disulfide bridge in the folding and stability of the recombinant human prion protein. J Biol Chem 276:2427-2431
87. Caughey B, Lansbury PT (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26: 267-298 (Pubitemid 37064935)
88. Silveira JR, Raymond GJ, Hughson AG et al (2005) The most infectious prion protein particles. Nature 437:257-261 (Pubitemid 41294488)
89. Jarrett JT, Lansbury PT (1993) Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73:1055-1058 (Pubitemid 23180480)
90. Osherovich LZ, Weissman JS (2002) The utility of prions. Dev Cell 2:143-151 (Pubitemid 38351579)
91. Uptain SM, Lindquist S (2002) Prions as protein-based genetic elements. Annu Rev Microbiol 56:703-741 (Pubitemid 35217472)
92. Tanaka M, Collins SR, Toyama BH et al (2006) The physical basis of how prion conformations determine strain phenotypes. Nature 442:585-589 (Pubitemid 44167919)
93. Shorter J, Lindquist S (2006) Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities. Mol Cell 23:425-438 (Pubitemid 44128844)
94. Knowles TPJ, Waudby CA, Devlin GL et al (2009) An analytical solution to the kinetics of breakable filament assembly. Science 326:1533-1537
95. Bolton DC, McKinley MP, Prusiner SB (1982) Identification of a protein that purifies with the scrapie prion. Science 218:1309-1311
96. Zou W, Capellari S, Parchi P et al (2003) Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease. J Biol Chem 278:40429-40436 (Pubitemid 37280852)
97. Kong Q, Surewicz WK, Petersen RB et al (2004) Inherited prion diseases. In: Prusiner SB (ed) Prion biology and diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
98. Safar J, Wille H, Itri V et al (1998) Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 4:1157-1165 (Pubitemid 28468829)
99. Safar JG, Geschwind MD, Deering C et al (2005) Diagnosis of human prion disease. Proc Natl Acad Sci USA 102:3501-3506 (Pubitemid 40328074)
100. Pastrana MA, Sajnani G, Onisko B et al (2006) Isolation and characterization of a proteinase K-sensitive PrPSc fraction. Biochemistry 45:15710-15717 (Pubitemid 46032491)
101. Caughey BW, Dong A, Bhat KS et al (1991) Secondary structure analysis of the scrapieassociated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30:7672-7680
102. Gasset M, Baldwin MA, Fletterick RJ et al (1993) Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc Natl Acad Sci USA 90:1-5 (Pubitemid 23010237)
103. Pan KM, Baldwin M, Nguyen J et al (1993) Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 90: 10962-10966
104. Safar J, Roller PP, Gajdusek DC et al (1993) Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity. Protein Sci 2:2206-2216 (Pubitemid 23354723)
105. Smirnovas V, Baron GS, Offerdahl DK et al (2011) Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange. Nat Struct Mol Biol 18: 504-506
106. Sunde M, Serpell LC, Bartlam M et al (1997) Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol 273:729-739 (Pubitemid 27488813)
107. King C, Diaz-Avalos R (2004) Protein-only transmission of three yeast prion strains. Nature 428:319-323 (Pubitemid 38418802)
108. Tanaka M, Chien P, Naber N et al (2004) Conformational variations in an infectious protein determine prion strain differences. Nature 428:323-328 (Pubitemid 38418803)
109. Jansen C, Parchi P, Capellari S et al (2010) Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. Acta Neuropathol 119:189-197
110. Ghetti B, Piccardo P, Spillantini MG et al (1996) Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci USA 93:744-748 (Pubitemid 26041161)
111. Chesebro B, Trifilo M, Race R et al (2005) Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308:1435-1439 (Pubitemid 40791292)
112. Chesebro B, Race B, Meade-White K et al (2010) Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring. PLoS Pathog 6:e1000800
113. Sim VL, Caughey B (2009) Ultrastructures and strain comparison of under-glycosylated scrapie prion fibrils. Neurobiol Aging 30:2031-2042
114. Caughey B, Baron GS, Chesebro B et al (2009) Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem 78:177-204
115. Prusiner SB, McKinley MP, Bowman KA et al (1983) Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35:349-358 (Pubitemid 14202913)
116. McKinley MP, Meyer RK, Kenaga L et al (1991) Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J Virol 65:1340-1351
117. Riesner D, Kellings K, Post K et al (1996) Disruption of prion rods generates 10-nm spherical particles having high alpha-helical content and lacking scrapie infectivity. J Virol 70:1714-1722 (Pubitemid 26062931)
118. Wille H, Michelitsch MD, Guénebaut V et al (2002) Structural studies of the scrapie prion protein by electron crystallography. Proc Natl Acad Sci USA 99:3563-3568 (Pubitemid 34252147)
119. Govaerts C, Wille H, Prusiner SB et al (2004) Evidence for assembly of prions with lefthanded beta-helices into trimers. Proc Natl Acad Sci USA 101:8342-8347 (Pubitemid 38736577)
120. Kostrewa D, D'Arcy A, Takacs B et al (2001) Crystal structures of Streptococcus pneumoniae N-acetylglucosamine-1-phosphate uridyltransferase, GlmU, in apo form at 2.33 A resolution and in complex with UDP-N- acetylglucosamine and Mg(2+) at 1.96 A resolution. J Mol Biol 305:279-289 (Pubitemid 32099461)
121. DeMarco ML, Daggett V (2004) From conversion to aggregation: protofibril formation of the prion protein. Proc Natl Acad Sci USA 101:2293-2298 (Pubitemid 38269305)
122. Cobb NJ, Sonnichsen FD, Mchaourab H et al (2007) Molecular architecture of human prion protein amyloid: a parallel, in-register b-structure. Proc Natl Acad Sci USA 104: 18946-18951
123. Wiltzius JJW, Landau M, Nelson R et al (2009) Molecular mechanisms for protein-encoded inheritance. Nat Struct Mol Biol 16:973-978
124. Wille H, Bian W, McDonald Met al (2009) Natural and synthetic prion structure from X-ray fiber diffraction. Proc Natl Acad Sci USA 106:16990-16995
125. Wasmer C, Lange A, Van Melckebeke H et al (2008) Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core. Science 319:1523-1526 (Pubitemid 351398180)
126. Shewmaker F, McGlinchey RP, Thurber KR et al (2009) The functional curli amyloid is not based on in-register parallel beta-sheet structure. J Biol Chem 284:25065-25076
127. Baskakov IV, Legname G, Prusiner SB et al (2001) Folding of prion protein to its native alpha-helical conformation is under kinetic control. J Biol Chem 276:19687-19690
128. Lee S, Eisenberg D (2003) Seeded conversion of recombinant prion protein to a disulfidebonded oligomer by a reduction-oxidation process. Nat Struct Biol 10:725-730 (Pubitemid 37052411)
129. Tahiri-Alaoui A, Gill AC, Disterer P et al (2004) Methionine 129 variant of human prion protein oligomerizes more rapidly than the valine 129 variant: implications for disease susceptibility to Creutzfeldt-Jakob disease. J Biol Chem 279:31390-31397 (Pubitemid 39037806)
130. O'Sullivan DBD, Jones CE, Abdelraheim SR et al (2007) NMR characterization of the pH 4 beta-intermediate of the prion protein: the N-terminal half of the protein remains unstructured and retains a high degree of flexibility. Biochem J 401:533-540 (Pubitemid 46166434)
131. Hosszu LLP, Trevitt CR, Jones S et al (2009) Conformational properties of b-PrP. J Biol Chem 284:21981-21990
132. Baskakov IV, Legname G, Baldwin MA et al (2002) Pathway complexity of prion protein assembly into amyloid. J Biol Chem 277:21140-21148 (Pubitemid 34952249)
133. Baskakov IV, Legname G, Gryczynski Z et al (2004) The peculiar nature of unfolding of the human prion protein. Protein Sci 13:586-595 (Pubitemid 38252555)
134. Apetri AC, Vanik DL, SurewiczWK (2005) Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231. Biochemistry 44:15880-15888 (Pubitemid 41746918)
135. Bocharova OV, Breydo L, Parfenov AS et al (2005) In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc). J Mol Biol 346:645-659
136. Stohr J, Weinmann N, Wille H et al (2008) Mechanisms of prion protein assembly into amyloid. Proc Natl Acad Sci USA 105:2409-2414 (Pubitemid 351520527)
137. Cobb NJ, Apetri AC, Surewicz WK (2008) Prion protein amyloid formation under nativelike conditions involves refolding of the C-terminal alpha-helical domain. J Biol Chem 283: 34704-34711
138. Bocharova OV, Breydo L, Salnikov VV et al (2005) Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt-Jakob disease. Protein Sci 14:1222-1232 (Pubitemid 40577802)
139. Bocharova OV, Makarava N, Breydo L et al (2006) Annealing prion protein amyloid fibrils at high temperature results in extension of a proteinase K-resistant core. J Biol Chem 281: 2373-2379 (Pubitemid 43845828)
140. Makarava N, Kovacs GG, Bocharova O et al (2010) Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol 119:177-187
141. Atarashi R, Moore RA, Sim VL et al (2007) Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods 4:645-650 (Pubitemid 47202476)
142. Smirnovas V, Kim J, Lu X et al (2009) Distinct structures of scrapie prion protein (PrPSc)-seeded versus spontaneous recombinant prion protein fibrils revealed by hydrogen/deuterium exchange. J Biol Chem 284:24233-24241
143. Lu X, Wintrode PL, Surewicz WK (2007) Beta-sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange. Proc Natl Acad Sci USA 104: 1510-1515 (Pubitemid 46214621)
144. Kumar J, Sreeramulu S, Schmidt TL et al (2010) Prion protein amyloid formation involves structural rearrangements in the C-terminal domain. Chembiochem 11:1208-1213
145. Tycko R, Savtchenko R, Ostapchenko VG et al (2010) The a-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel b-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance. Biochemistry 49:9488-9497
146. Helmus JJ, Surewicz K, Nadaud PS et al (2008) Molecular conformation and dynamics of the Y145Stop variant of human prion protein in amyloid fibrils. Proc Natl Acad Sci USA 105:6284-6289 (Pubitemid 351758338)
147. Walsh P, Simonetti K, Sharpe S (2009) Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein. Structure 17:417-426
148. Lee S, Mou Y, Lin S et al (2008) Steric zipper of the amyloid fibrils formed by residues 109-122 of the Syrian hamster prion protein. J Mol Biol 378:1142-1154
149. Sawaya MR, Sambashivan S, Nelson R et al (2007) Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 447:453-457 (Pubitemid 46816731)
150. Nelson R, Sawaya MR, BalbirnieMet al (2005) Structure of the cross-beta spine of amyloidlike fibrils. Nature 435:773-778 (Pubitemid 40839722)
151. Apostol MI, Sawaya MR, Cascio D et al (2010) Crystallographic studies of PrP segments suggest how structural changes encoded by polymorphism at residue 129 modulate susceptibility to human prion disease. J Biol Chem 285:29671-29675
152. Collinge J, Clarke AR (2007) A general model of prion strains and their pathogenicity. Science 318:930-936 (Pubitemid 350098981)
153. Gambetti P, Cali I, Notari S et al (2011) Molecular biology and pathology of prion strains in sporadic human prion diseases. Acta Neuropathol 121:79-90
154. Li J, Browning S, Mahal SP et al (2010) Darwinian evolution of prions in cell culture. Science 327:869-872
155. Bessen RA, Marsh RF (1992) Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 66:2096-2101
156. Bessen RA, Marsh RF (1994) Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68:7859-7868 (Pubitemid 24362673)
157. Caughey B, Raymond GJ, Bessen RA (1998) Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J Biol Chem 273:32230-32235 (Pubitemid 29177169)
158. Peretz D, Scott MR, Groth D et al (2001) Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci 10:854-863 (Pubitemid 32240511)
159. Cali I, Castellani R, Alshekhlee A et al (2009) Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 132:2643-2658
160. Dzwolak W, Smirnovas V, Jansen R et al (2004) Insulin forms amyloid in a strain-dependent manner: an FT-IR spectroscopic study. Protein Sci 13:1927-1932 (Pubitemid 38822132)
161. Petkova AT, Leapman RD, Guo Z et al (2005) Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 307:262-265 (Pubitemid 40116242)
162. Krishnan R, Lindquist SL (2005) Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 435:765-772 (Pubitemid 40839721)
163. Toyama BH, Kelly MJS, Gross JD et al (2007) The structural basis of yeast prion strain variants. Nature 449:233-237 (Pubitemid 47402368)
164. Petkova AT, Yau W, Tycko R (2006) Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. Biochemistry 45:498-512 (Pubitemid 43100415)
165. Makarava N, Baskakov IV (2008) The same primary structure of the prion protein yields two distinct self-propagating states. J Biol Chem 283:15988-15996
166. Ostapchenko VG, Sawaya MR, Makarava N et al (2010) Two amyloid states of the prion protein display significantly different folding patterns. J Mol Biol 400:908-921
167. Vanik DL, Surewicz KA, Surewicz WK (2004) Molecular basis of barriers for interspecies transmissibility of mammalian prions. Mol Cell 14:139-145 (Pubitemid 38469916)
168. Jones EM, Surewicz WK (2005) Fibril conformation as the basis of species-and straindependent seeding specificity of mammalian prion amyloids. Cell 121:63-72
169. Collinge J (1999) Variant Creutzfeldt-Jakob disease. Lancet 354:317-323 (Pubitemid 29348751)
170. Bruce ME, Dickinson AG (1987) Biological evidence that scrapie agent has an independent genome. J Gen Virol 68(Pt 1):79-89 (Pubitemid 17207190)
171. Wickner RB, Edskes HK, Roberts BT et al (2004) Prions: proteins as genes and infectious entities. Genes Dev 18:470-485 (Pubitemid 38372804)
172. Caughey B (2001) Interactions between prion protein isoforms: the kiss of death? Trends Biochem Sci 26:235-242 (Pubitemid 32289242)
173. Hill AF, Antoniou M, Collinge J (1999) Protease-resistant prion protein produced in vitro lacks detectable infectivity. J Gen Virol 80(Pt 1):11-14 (Pubitemid 29041673)
174. Saborio GP, Permanne B, Soto C (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411:810-813 (Pubitemid 32588105)
175. Castilla J, Saá P, Hetz C et al (2005) In vitro generation of infectious scrapie prions. Cell 121:195-206 (Pubitemid 40546388)
176. Castilla J, Morales R, Saá P et al (2008) Cell-free propagation of prion strains. EMBO J 27:2557-2566
177. Barria MA, Mukherjee A, Gonzalez-Romero D et al (2009) De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog 5:e1000421
178. Deleault NR, Harris BT, Rees JR et al (2007) Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 104:9741-9746 (Pubitemid 47175337)
179. Lee KS, Caughey B (2007) A simplified recipe for prions. Proc Natl Acad Sci USA 104: 9551-9552 (Pubitemid 47175303)
180. Legname G, Baskakov IV, Nguyen HB et al (2004) Synthetic mammalian prions. Science 305:673-676 (Pubitemid 39006757)
181. Colby DW, Giles K, Legname G et al (2009) Design and construction of diverse mammalian prion strains. Proc Natl Acad Sci USA 106:20417-20422
182. Weissmann C (2005) Birth of a prion: spontaneous generation revisited. Cell 122:165-168 (Pubitemid 41032981)
183. Bieschke J, Weber P, Sarafoff N et al (2004) Autocatalytic self-propagation of misfolded prion protein. Proc Natl Acad Sci USA 101:12207-12211 (Pubitemid 39145421)
184. Kim J, Surewicz K, Gambetti P et al (2009) The role of glycophosphatidylinositol anchor in the amplification of the scrapie isoform of prion protein in vitro. FEBS Lett 583:3671-3675
185. Wang F, Wang X, Yuan C et al (2010) Generating a prion with bacterially expressed recombinant prion protein. Science 327:1132-1135
186. Kim J, Cali I, Surewicz K et al (2010) Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem 285: 14083-14087